ParenteralDosed ingredient Cosmetic cross-reference

Sodium Citrate

CAS 68-04-2

Sodium Citrate (CAS 68-04-2) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 1,517 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
4
SOURCE DrugCentral
Adverse signals
1,517
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Citrate
CAS Number
68-04-2
UNII
RS7A450LGA
InChIKey
HRXKRNGNAMMEHJ-UHFFFAOYSA-K
ChEMBL ID
CHEMBL1355
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
ANHYDROUS TRISODIUM CITRATE
dosed ingredientnatural productparenteral
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1355 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 4 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 87714.28571428571 nM 7 -
- Ki 42599.666666666664 nM 3 -
Carbonic anhydrase 4
Enzyme
 Ki 7 - Homo sapiens
Carbonic anhydrase
Enzyme
 Ki 4.41 - Candida albicans (strain SC5314 / ATCC MYA-2876)
SOURCE DrugCentral 46 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Paraesthesia 5331 18116.612 10033775
Feeling hot 2686 10224.233 10016334
Pallor 2473 9770.689 10033546
Hyperhidrosis 2123 5568.877 10020642
Thirst 1303 5521.073 10043458
Dizziness 2725 4520.118 10013573
Nausea 2877 3331.363 10028813
Dysgeusia 1038 2925.617 10013911
Vision blurred 1134 2566.056 10047513
Asthenia 1308 1340.764 10003549
Dyspepsia 707 1274.514 10013946
Restlessness 523 1269.854 10038743
Chills 695 1029.332 10008531
Injection site haematoma 240 817.565 10022066
Toxic anterior segment syndrome 177 724.932 10066366
Appendicolith 144 424.013 10074458
Drug ineffective 50 348.206 10013709
Tetany 91 323.515 10043380
Fatigue 29 316.62 10016256
Diarrhoea 19 291.176 10012735
Appendicitis 144 284.222 10003011
Neck pain 214 231.328 10028836
Pyrexia 12 217.054 10037660
Abdominal pain 465 209.729 10000081
Cardiogenic shock 145 202.003 10007625
Palpitations 249 201.448 10033557
Arthralgia 15 196.079 10003239
Rash 20 191.611 10037844
Endophthalmitis 73 167.309 10014801
Dyspnoea 66 167.094 10013968
Pneumonia 39 155.361 10035664
Ventricular fibrillation 112 154.612 10047290
Blood phosphorus increased 74 152.335 10050196
Fall 14 142.848 10016173
Malaise 18 138.711 10025482
Death 49 133.105 10011906
Pruritus 10 130.339 10037087
Weight decreased 7 123.741 10047895
Decreased appetite 4 120.235 10061428
Hypertension 6 115.543 10020772
Ascites 145 114.417 10003445
Acute kidney injury 26 112.355 10069339
Stress 148 110.586 10042209
Drug interaction 12 109.731 10013710
Weight increased 3 109.312 10047899
Cough 11 109.137 10011224

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 8 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Sodium Citrate 56466 SU MTHSPL
sodium citrate 56466 SU MTHSPL
SODIUM CITRATE 56466 SU MTHSPL
Sodium citrate 56466 SU MTHSPL
ANHYDROUS TRISODIUM CITRATE 1310549 SU MTHSPL
Anhydrous Trisodium Citrate 1310549 SU MTHSPL
anhydrous trisodium citrate 1310549 SU MTHSPL
sodium citrate 56466 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Citrate used for in pharmaceutical contexts?

Sodium Citrate (CAS 68-04-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Citrate?

Sodium Citrate has 1,517 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Paraesthesia, Feeling hot, Pallor, Hyperhidrosis, Thirst. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Citrate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Citrate with EU status "permitted".

What clinical phase is Sodium Citrate in?

Sodium Citrate is rendered with ChEMBL max phase 4 (approved).

What bioactivity targets are documented for Sodium Citrate?

Sodium Citrate has 4 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 4, Carbonic anhydrase.